A Study to Evaluate a Modified Contact Lens
Primary Purpose
Myopia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
SofLens in investigational solution
SofLens in currently marketed solution
Sponsored by
About this trial
This is an interventional treatment trial for Myopia focused on measuring ocular irritation
Eligibility Criteria
Inclusion Criteria:
- Subjects must be free of any anterior segment disorders.
- Subjects must be adapted lens wearers and wear a lens in each eye and each lens must be of the same manufacture and brand.
- Subjects must be myopic and require contact lens correction from -0.50 D to -6.00 D in each eye.
- Subjects must be habitual wearers of daily disposable or planned replacement (at least every 3 months) soft contact lenses.
- Subjects must live/work in an urban environment at least 6 hours per day and for at least 4 days per week throughout the duration of the study.
- Subjects must be willing and able to wear the study lenses on a daily wear basis while in an urban environment.
- Subjects living/working in the urban environment must feel challenged by harsh, drying outdoor conditions (ie dust, pollution, smog).
- Subjects must feel that being in an urban environment has a negative effect on their lens wearing experience.
- Subjects must have access to an internet connection and be able to send and receive email.
Exclusion Criteria:
- Subjects who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
- Subjects with any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study.
- Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
- Subjects with an active ocular disease or who are using any ocular medication.
- Subjects with any grade 2 or greater finding during the slit lamp examination
- Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
- Subjects with any scar or neovascularization within the central 4 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
- Subjects who are allergic to any component in the study care products.
Sites / Locations
- Bausch & Lomb, Inc.
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
SofLens in investigational solution
SofLens in currently marketed solution
Arm Description
Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.
SofLens daily disposable contact lens packaged in currently marketed storage solution.
Outcomes
Primary Outcome Measures
Percentage of Eyes With > Grade 2 Slit Lamp Findings
Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding > grade 2, across abnormalities.
Visual Acuity
Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).
Secondary Outcome Measures
Symptoms and Complaints
Symptoms and complaints were assessed on a scale from 0 to 100, with 0 denoting the most unfavorable symptoms/complaints. Symptoms/complaints were collected by eye from each participant and based on the participant's experience with the study lenses. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, and Overall impression.
Full Information
NCT ID
NCT01391364
First Posted
June 16, 2011
Last Updated
September 9, 2020
Sponsor
Bausch & Lomb Incorporated
1. Study Identification
Unique Protocol Identification Number
NCT01391364
Brief Title
A Study to Evaluate a Modified Contact Lens
Official Title
A Study to Evaluate the Product Performance of a Modified Contact Lens
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Completed
Study Start Date
April 2011 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bausch & Lomb Incorporated
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study is being conducted to evaluate the product performance of SofLens daily disposable contact lenses packaged in an investigational Test solution versus SofLens daily disposable contact lenses packaged in the currently marketed solution (Control), as it relates to comfort when worn by adapted soft contact lens wearers on a daily-wear basis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia
Keywords
ocular irritation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
438 (Actual)
8. Arms, Groups, and Interventions
Arm Title
SofLens in investigational solution
Arm Type
Experimental
Arm Description
Bausch + Lomb SofLens daily disposable contact lens packaged in an investigational storage solution.
Arm Title
SofLens in currently marketed solution
Arm Type
Active Comparator
Arm Description
SofLens daily disposable contact lens packaged in currently marketed storage solution.
Intervention Type
Device
Intervention Name(s)
SofLens in investigational solution
Intervention Description
SofLens in investigational solution, worn on a daily disposable basis for 7 days.
Intervention Type
Device
Intervention Name(s)
SofLens in currently marketed solution
Intervention Description
SofLens packaged in currently marketed solution, worn on a daily disposable basis for 7 days.
Primary Outcome Measure Information:
Title
Percentage of Eyes With > Grade 2 Slit Lamp Findings
Description
Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding). The outcome measure is any finding > grade 2, across abnormalities.
Time Frame
At 2 weeks follow up
Title
Visual Acuity
Description
Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).
Time Frame
At 2 weeks follow up
Secondary Outcome Measure Information:
Title
Symptoms and Complaints
Description
Symptoms and complaints were assessed on a scale from 0 to 100, with 0 denoting the most unfavorable symptoms/complaints. Symptoms/complaints were collected by eye from each participant and based on the participant's experience with the study lenses. Symptoms/complaints parameters included the following: Burning/stinging upon insertion, Comfort upon insertion, Overall comfort, Comfort at end of day, Ease of handling/insertion, Ease of handling/removal, Dryness, Itchiness, Redness, Vision upon insertion, Vision, Vision in low light, Lens cleanness upon insertion, Lens cleanness upon removal, and Overall impression.
Time Frame
At 2 weeks follow up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects must be free of any anterior segment disorders.
Subjects must be adapted lens wearers and wear a lens in each eye and each lens must be of the same manufacture and brand.
Subjects must be myopic and require contact lens correction from -0.50 D to -6.00 D in each eye.
Subjects must be habitual wearers of daily disposable or planned replacement (at least every 3 months) soft contact lenses.
Subjects must live/work in an urban environment at least 6 hours per day and for at least 4 days per week throughout the duration of the study.
Subjects must be willing and able to wear the study lenses on a daily wear basis while in an urban environment.
Subjects living/working in the urban environment must feel challenged by harsh, drying outdoor conditions (ie dust, pollution, smog).
Subjects must feel that being in an urban environment has a negative effect on their lens wearing experience.
Subjects must have access to an internet connection and be able to send and receive email.
Exclusion Criteria:
Subjects who have worn gas permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last three months.
Subjects with any systemic disease currently affecting ocular health or which in the Investigator's opinion may have an effect on ocular health during the course of the study.
Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
Subjects with an active ocular disease or who are using any ocular medication.
Subjects with any grade 2 or greater finding during the slit lamp examination
Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
Subjects with any scar or neovascularization within the central 4 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
Subjects who are allergic to any component in the study care products.
Facility Information:
Facility Name
Bausch & Lomb, Inc.
City
Rochester
State/Province
New York
ZIP/Postal Code
14609
Country
United States
12. IPD Sharing Statement
Learn more about this trial
A Study to Evaluate a Modified Contact Lens
We'll reach out to this number within 24 hrs